Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 11Lung Neoplasms 7Breast Neoplasms 7Liver Neoplasms 6Carcinoma, Hepatocellular 5Prostatic Neoplasms 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Pain 3Melanoma 3Keratosis, Actinic 3Esophageal Neoplasms 3Small Cell Lung Carcinoma 2Rectal Neoplasms 2Ovarian Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Biliary Tract Neoplasms 2Barrett Esophagus 2Wilms Tumor 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Pancreatic Cancer 1Tongue Neoplasms 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Cryosurgery × Clear all
NCT04701918 2026-01-22

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Massachusetts General Hospital

Phase 2 Completed
9 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡